11-67290444-C-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_207354.3(ANKRD13D):c.349C>G(p.Gln117Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000038 in 1,577,220 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/24 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_207354.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152184Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000104 AC: 2AN: 192452 AF XY: 0.0000195 show subpopulations
GnomAD4 exome AF: 0.00000211 AC: 3AN: 1424918Hom.: 0 Cov.: 31 AF XY: 0.00000284 AC XY: 2AN XY: 704972 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152302Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 3AN XY: 74464 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.349C>G (p.Q117E) alteration is located in exon 3 (coding exon 3) of the ANKRD13D gene. This alteration results from a C to G substitution at nucleotide position 349, causing the glutamine (Q) at amino acid position 117 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at